APA (7th ed.) Citation

LR, H., I, C., C, B., A, N., M, B., T, S., . . . C, M. (2023). Pseudoprogression in patients with uterine leiomyosarcoma treated with first-line single-agent doxorubicin. European journal of cancer (Oxford, England : 1990), 192, 113261. https://doi.org/10.1016/j.ejca.2023.113261

Chicago Style (17th ed.) Citation

LR, Howroyd, et al. "Pseudoprogression in Patients with Uterine Leiomyosarcoma Treated with First-line Single-agent Doxorubicin." European Journal of Cancer (Oxford, England : 1990) 192 (2023): 113261. https://doi.org/10.1016/j.ejca.2023.113261.

MLA (9th ed.) Citation

LR, Howroyd, et al. "Pseudoprogression in Patients with Uterine Leiomyosarcoma Treated with First-line Single-agent Doxorubicin." European Journal of Cancer (Oxford, England : 1990), vol. 192, 2023, p. 113261, https://doi.org/10.1016/j.ejca.2023.113261.